According to research published in the journal Cellular and Molecular Life Sciences, more than 140 scientific studies have shown that melatonin is an effective drug in the treatment of SARS-CoV-2.1 Despite this, melatonin, with its known antiviral and anti-inflammatory effects, has received little attention as a countermeasure against COVID-19.
After reviewing the published literature related to melatonin and SARS-CoV-2/COVID-19 in November 2021, the research team found that melatonin is most commonly studied for its inhibition of inflammation and its association with COVID-19 ability of cytokine storm.2 Treatment of people infected with SARS-CoV-2 with melatonin is another common theme.
Overall, these data provide a rationale for the use of melatonin as a preventive and therapeutic tool for COVID-19. When COVID-19 patients took melatonin alone or in combination with other treatments, the severity of infection was reduced, mortality was lower, and length of hospital stay was shorter.
“The ability of melatonin to prevent SARS-CoV-2 infection may reduce healthcare exhaustion by limiting the need for hospitalization,” the researchers noted, adding that it was also safe — “melatonin was Has a high safety profile and lacks significant efficacy. Toxicity.”3
One reason melatonin works as an anti-COVID-19 drug is because of its antiseptic (blood poisoning) effects. The researchers explained:4
“While SARS-CoV-2 infection is generally thought of as a pulmonary problem, the consequences of this infection go beyond the respiratory system. Eventually, the disease becomes systemic as severe sepsis or septic shock develops leading to multiorgan failure. disease, which often leads to death in patients infected with SARS-CoV-2.”
Sepsis is a life-threatening disease caused by a systemic infection that causes your body to overreact and trigger an excessive and highly damaging immune response.Melatonin prevents death in newborns with severe bacterial sepsis5 And it also appears that septic shock symptoms can be reversed by:6